Literature DB >> 18317426

Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein.

Manfredi Rizzo1, Egle Corrado, Giuseppe Coppola, Ida Muratori, Salvatore Novo.   

Abstract

BACKGROUND: Several studies have suggested that inflammation and infection may be important for accelerated progression of atherosclerosis, but few data are available on subjects with early stages of atherosclerosis. METHODS AND
RESULTS: We included, in a prospective 5-year follow-up study, 150 patients with subclinical carotid atherosclerosis, evaluating at baseline all established traditional cardiovascular risk factors (eg, older age, male sex, obesity, hypertension, diabetes, smoking, family history of coronary artery disease, and dyslipidemia); 2 markers of inflammation, fibrinogen, and high-sensitivity C-reactive protein (CRP); and the seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus. After follow-up, cardiovascular and cerebrovascular events were registered in the 19% of patients, and the increment in CRP levels (in quintiles) was significantly associated with ischemic stroke (P = 0.0253), acute myocardial infarction (P = 0.0055), cardiovascular or cerebrovascular death (P = 0.0145), and the presence of any event (P = 0.0064). Most traditional cardiovascular risk factors (eg, older age, hypertension, diabetes, and dyslipidemia) were significantly associated with the events but only in the unadjusted analysis; in fact, at logistic regression analysis, among all baseline variables, only elevated CRP levels showed a predictive role (odds ratio, 7.0; 95% confidence interval, 2.2-18.4; P = 0.0247).
CONCLUSIONS: Our findings suggest that elevated CRP concentrations may significantly influence the occurrence of cerebrovascular and cardiovascular events in patients with baseline subclinical carotid atherosclerosis. Notably, null findings were obtained by viral and bacteria titers, suggesting a greater role of inflammation (and not of infection) in the progression of atherosclerosis in our cohort. However, further studies are needed to evaluate the therapeutic implications in this category of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317426     DOI: 10.2310/jim.0b013e31816204ab

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  4 in total

1.  Association of risk factors for atherosclerosis, including high-sensitivity C-reactive protein, with carotid intima-media thickness, plaque score, and pulse wave velocity in a male population.

Authors:  Satoko Ojima; Takuro Kubozono; Shin Kawasoe; Takeko Kawabata; Masaaki Miyata; Hironori Miyahara; Shigeho Maenohara; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2020-01-24       Impact factor: 3.872

2.  Total cholesterol and LDL levels decrease before rheumatoid arthritis.

Authors:  Elena Myasoedova; Cynthia S Crowson; Hilal Maradit Kremers; Patrick D Fitz-Gibbon; Terry M Therneau; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2009-10-23       Impact factor: 19.103

3.  Blood pressure and stature in Helicobacter pylori positive and negative persons.

Authors:  Marcela Kopacova; Ilona Koupil; Bohumil Seifert; Miluska Skodova Fendrichova; Jana Spirkova; Viktor Vorisek; Stanislav Rejchrt; Tomas Douda; Ilja Tacheci; Jan Bures
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

4.  Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population.

Authors:  Min Jung Park; Seung Ho Choi; Donghee Kim; Seung Joo Kang; Su Jin Chung; Su Yeon Choi; Dae Hyun Yoon; Seon Hee Lim; Young Sun Kim; Jeong Yoon Yim; Joo Sung Kim; Hyun Chae Jung
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.